Redefining the risks of prenatally ascertained supernumerary marker chromosomes: A collaborative study

M. D. Graf, L. Christ, J. T. Mascarello, P. Mowrey, M. Pettenati, G. Stetten, P. Storto, U. Surti, D. L. Van Dyke, G. H. Vance, D. Wolff, Stuart Schwartz

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background: A marker chromosome is defined as a structurally abnormal chromosome that cannot be identified by routine cytogenetics. The risk for phenotypic abnormalities associated with a marker chromosome depends on several factors, including inheritance, mode of ascertainment, chromosomal origin, and the morphology, content, and structure of the marker. Methods: to understand the karyotype-phenotype relationship of prenatally ascertained supernumerary de novo marker chromosomes, we combined data from prenatal cases obtained from 12 laboratories with those from studies in the literature. We were able to obtain cytogenetic and phenotypic data from 108 prenatally ascertained supernumerary de novo marker chromosomes to refine the phenotypic risk associated with these markers. Because of the growing number of cases and because more techniques are available to delineate marker morphology, we have been able to group risk estimates into subcategories, such as by marker type and whether there are ultrasound abnormalities. Results: If a de novo supernumerary marker chromosome is found prenatally, our data suggest there is a 26% risk for phenotypic abnormality when there is no other information defining the marker (such as chromosomal origin or information about the existing phenotype). However, if high resolution ultrasound studies are normal, this risk reduces to 18%. Conclusions: Our findings strongly support the value of additional genetic studies for more precisely defining the risk in individual cases involving marker chromosomes.

Original languageEnglish (US)
Pages (from-to)660-664
Number of pages5
JournalJournal of Medical Genetics
Volume43
Issue number8
DOIs
StatePublished - Aug 2006
Externally publishedYes

Fingerprint

Chromosomes, Human, 1-3
Genetic Markers
Cytogenetics
Phenotype
Karyotype
Chromosomes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Graf, M. D., Christ, L., Mascarello, J. T., Mowrey, P., Pettenati, M., Stetten, G., ... Schwartz, S. (2006). Redefining the risks of prenatally ascertained supernumerary marker chromosomes: A collaborative study. Journal of Medical Genetics, 43(8), 660-664. https://doi.org/10.1136/jmg.2005.037887

Redefining the risks of prenatally ascertained supernumerary marker chromosomes : A collaborative study. / Graf, M. D.; Christ, L.; Mascarello, J. T.; Mowrey, P.; Pettenati, M.; Stetten, G.; Storto, P.; Surti, U.; Van Dyke, D. L.; Vance, G. H.; Wolff, D.; Schwartz, Stuart.

In: Journal of Medical Genetics, Vol. 43, No. 8, 08.2006, p. 660-664.

Research output: Contribution to journalArticle

Graf, MD, Christ, L, Mascarello, JT, Mowrey, P, Pettenati, M, Stetten, G, Storto, P, Surti, U, Van Dyke, DL, Vance, GH, Wolff, D & Schwartz, S 2006, 'Redefining the risks of prenatally ascertained supernumerary marker chromosomes: A collaborative study', Journal of Medical Genetics, vol. 43, no. 8, pp. 660-664. https://doi.org/10.1136/jmg.2005.037887
Graf, M. D. ; Christ, L. ; Mascarello, J. T. ; Mowrey, P. ; Pettenati, M. ; Stetten, G. ; Storto, P. ; Surti, U. ; Van Dyke, D. L. ; Vance, G. H. ; Wolff, D. ; Schwartz, Stuart. / Redefining the risks of prenatally ascertained supernumerary marker chromosomes : A collaborative study. In: Journal of Medical Genetics. 2006 ; Vol. 43, No. 8. pp. 660-664.
@article{c0a9d97348094f778b42c380ea278b28,
title = "Redefining the risks of prenatally ascertained supernumerary marker chromosomes: A collaborative study",
abstract = "Background: A marker chromosome is defined as a structurally abnormal chromosome that cannot be identified by routine cytogenetics. The risk for phenotypic abnormalities associated with a marker chromosome depends on several factors, including inheritance, mode of ascertainment, chromosomal origin, and the morphology, content, and structure of the marker. Methods: to understand the karyotype-phenotype relationship of prenatally ascertained supernumerary de novo marker chromosomes, we combined data from prenatal cases obtained from 12 laboratories with those from studies in the literature. We were able to obtain cytogenetic and phenotypic data from 108 prenatally ascertained supernumerary de novo marker chromosomes to refine the phenotypic risk associated with these markers. Because of the growing number of cases and because more techniques are available to delineate marker morphology, we have been able to group risk estimates into subcategories, such as by marker type and whether there are ultrasound abnormalities. Results: If a de novo supernumerary marker chromosome is found prenatally, our data suggest there is a 26{\%} risk for phenotypic abnormality when there is no other information defining the marker (such as chromosomal origin or information about the existing phenotype). However, if high resolution ultrasound studies are normal, this risk reduces to 18{\%}. Conclusions: Our findings strongly support the value of additional genetic studies for more precisely defining the risk in individual cases involving marker chromosomes.",
author = "Graf, {M. D.} and L. Christ and Mascarello, {J. T.} and P. Mowrey and M. Pettenati and G. Stetten and P. Storto and U. Surti and {Van Dyke}, {D. L.} and Vance, {G. H.} and D. Wolff and Stuart Schwartz",
year = "2006",
month = "8",
doi = "10.1136/jmg.2005.037887",
language = "English (US)",
volume = "43",
pages = "660--664",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - Redefining the risks of prenatally ascertained supernumerary marker chromosomes

T2 - A collaborative study

AU - Graf, M. D.

AU - Christ, L.

AU - Mascarello, J. T.

AU - Mowrey, P.

AU - Pettenati, M.

AU - Stetten, G.

AU - Storto, P.

AU - Surti, U.

AU - Van Dyke, D. L.

AU - Vance, G. H.

AU - Wolff, D.

AU - Schwartz, Stuart

PY - 2006/8

Y1 - 2006/8

N2 - Background: A marker chromosome is defined as a structurally abnormal chromosome that cannot be identified by routine cytogenetics. The risk for phenotypic abnormalities associated with a marker chromosome depends on several factors, including inheritance, mode of ascertainment, chromosomal origin, and the morphology, content, and structure of the marker. Methods: to understand the karyotype-phenotype relationship of prenatally ascertained supernumerary de novo marker chromosomes, we combined data from prenatal cases obtained from 12 laboratories with those from studies in the literature. We were able to obtain cytogenetic and phenotypic data from 108 prenatally ascertained supernumerary de novo marker chromosomes to refine the phenotypic risk associated with these markers. Because of the growing number of cases and because more techniques are available to delineate marker morphology, we have been able to group risk estimates into subcategories, such as by marker type and whether there are ultrasound abnormalities. Results: If a de novo supernumerary marker chromosome is found prenatally, our data suggest there is a 26% risk for phenotypic abnormality when there is no other information defining the marker (such as chromosomal origin or information about the existing phenotype). However, if high resolution ultrasound studies are normal, this risk reduces to 18%. Conclusions: Our findings strongly support the value of additional genetic studies for more precisely defining the risk in individual cases involving marker chromosomes.

AB - Background: A marker chromosome is defined as a structurally abnormal chromosome that cannot be identified by routine cytogenetics. The risk for phenotypic abnormalities associated with a marker chromosome depends on several factors, including inheritance, mode of ascertainment, chromosomal origin, and the morphology, content, and structure of the marker. Methods: to understand the karyotype-phenotype relationship of prenatally ascertained supernumerary de novo marker chromosomes, we combined data from prenatal cases obtained from 12 laboratories with those from studies in the literature. We were able to obtain cytogenetic and phenotypic data from 108 prenatally ascertained supernumerary de novo marker chromosomes to refine the phenotypic risk associated with these markers. Because of the growing number of cases and because more techniques are available to delineate marker morphology, we have been able to group risk estimates into subcategories, such as by marker type and whether there are ultrasound abnormalities. Results: If a de novo supernumerary marker chromosome is found prenatally, our data suggest there is a 26% risk for phenotypic abnormality when there is no other information defining the marker (such as chromosomal origin or information about the existing phenotype). However, if high resolution ultrasound studies are normal, this risk reduces to 18%. Conclusions: Our findings strongly support the value of additional genetic studies for more precisely defining the risk in individual cases involving marker chromosomes.

UR - http://www.scopus.com/inward/record.url?scp=33747081933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747081933&partnerID=8YFLogxK

U2 - 10.1136/jmg.2005.037887

DO - 10.1136/jmg.2005.037887

M3 - Article

C2 - 16882740

AN - SCOPUS:33747081933

VL - 43

SP - 660

EP - 664

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 8

ER -